Form 8-K - Current report:
SEC Accession No. 0000849146-25-000015
Filing Date
2025-02-05
Accepted
2025-02-05 16:06:17
Documents
15
Period of Report
2025-02-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lfvn-20250205.htm   iXBRL 8-K 27838
2 EX-99.1 earningsrelease_q2fy25.htm EX-99.1 257559
6 logoa18.jpg GRAPHIC 6462
  Complete submission text file 0000849146-25-000015.txt   441343

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20250205.xsd EX-101.SCH 1807
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20250205_lab.xml EX-101.LAB 22804
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20250205_pre.xml EX-101.PRE 13066
17 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20250205_htm.xml XML 2798
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

EIN.: 900224471 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35647 | Film No.: 25593267
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)